AiViva BioPharma Presents Two Abstracts/Presentations at ARVO 2024
May 5 - May 9
AiViva BioPharma is excited to present two Abstract/Presentations at The Association for Research in Vision & Ophthalmology (ARVO) conference in Seattle, Washington on May 5 and May 6, 2024.
The following will be presented by AiViva executives:
Presentation Number – Posterboard Number: 237 – B0300
Abstract/Presentation Title: Periocular injection of AIV007 in the Treatment of Macular Edema due to Neovascular Age-related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME): Preliminary Results of the Phase 1 Clinical Trial
Presenter: Yi Zhao, MD, PhD
Presentation Type: Poster Session
Session Number: 108
Session Title: AMD-1 (anti-VEGF)
Session Date/Times: May 5, 2024 from 8:00 AM to 9:45 AM
Presentation Number – Posterboard Number: 1946 – B0309
Abstract/Presentation Title: AIV007 Is a Potent Anti-angiogenic Agent with Anti-fibrotic Effect
Presenter: Yi Zhao, MD, PhD
Presentation Type: Poster Session
Session Number: 225
Session Title: AMD new drugs, delivery systems and mechanisms of action
Session Date/Times: May 6, 2024 from 8:30 AM to 10:15 AM
If you attend ARVO 2024, please stop by and say hello! We look forward to meeting you.
About ARVO: https://www.arvo.org/globalassets/arvo/about/press-room/arvo-fact-sheet.pdf
ARVO Schedule: https://www.arvo.org/globalassets/annual-meeting/arvo-2024/2024-schedule-at-a-glance.pdf